Patients and physicians do not adequately discuss patients' preferences for medical care at the end of life. Our objective was to perform a qualitative study using focus groups to identify barriers and facilitators to communication about end-of-life medical care for patients with AIDS and their physicians.
M
' any Americans fear loss of control over their lives if 9 they become critically ill mid worry that their dying will be prolonged, involve invasive therapy, and be imper sonal. 1 This concern is particularly important for those with chronic disease, There is substantial evidence, however, that physicians and patients do not adequately dis cuss patients' preferences for end of lffe medical care. ~ 4 The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT), a con trolled trial undertaken to improve care for critically ill in dividuals with chronic disease, found that less than 50% of physicians knew when their patients preferred to forgo cardiopulmonary resuscitation (CPR). c' Because physicians and patients may have different approaches to end of lffe decision making for AIDS than for other diseases/'J it is important to look at this disease separately. AIDS is the leading cause of death among men aged 15 to 44 years and the fourth leading cause of death among women in this age group, s In addition, AIDS dis proportionately affects individuals marginalized in our society. ' -a Many individuals with AIDS may be at risk of hay ing medical care withheld by a system with which they do not easily interact.in or of having inappropriately aggressive care because of inadequate communication with phy sicians. 11 '12 As a result, many persons with AIDS may be at increased risk of a "bad death,"
Several survey studies demonstrate that although a majority of patients with AIDS would like to talk with their physicians about end-of-life care, only a minority have had such a discussion. 4.1:n3 If patients believe that patient physician communication about end o51ife care is important and yet these discussions are infrequent, then substantial barriers to discussing end of lffe care must exist. Identification of the barriers to communication about end-of-life care is a necessary step to overcome them. 14ns The goal of this study is to identify and under stand the barriers and facilitators to discussing end of lffe care for patients with AIDS and their physicians,
METHODS
We conducted six focus groups with a total of 47 patients with AIDS and three focus groups with a total of 19 physicians with AIDS experience. The groups were con ducted between Jmmary and April of 1996, Each focus group comprised 6 to 11 subjects, a focus group leader with previous experience in qualitative research concern ing end-of-life care, and one of the investigators (as an observer). During each session, the leader asked several scripted, open-ended questions. After initial introductions, the leader asked the participants each if they had advance directives and whether they had discussed with their physician the kind of care they would wmlt if they became too ill to speak for themselves.
The initial question about barriers to end oglife dis cussion was "What are the things that make it hard to talk with your doctor about the kind of care you would want if you were too sick to speak for yourself?" Similarly, the initial question about facilitators to end-of-life discussion was "vVhat are the things that make it easier to talk with your doctor about the kind of care you would want if you were too sick to speak for yourself?," The leader would restate or rephrase the question when necessary to con tinue conversation on the topic. In addition, the leader probed participants to clarify the metaling of statements when necessary, facilitated discussion between group members, and asked members who remained quiet for their opinion, The leader did not offer possible barriers or facilitators to end of life discussions. A similar approach was used in the physician groups. Focus group sessions were audiotaped and transcribed verbatim.
Recruitment of Participants
Entry criteria for patients with AIDS were as follows:
at least 18 years of age, English speaking, an AIDS defining illness, lr' and CD4 count of less thin1 200, Patients were excluded if they had a diagnosis of dementia and their physician felt that their cognitive impairment would inter fere with participation in the group. Patients were recruited with flyers advertising for a focus group concerning patient physician communication, but not specifying the focus on end-of-life care, Flyers were posted in universityaffiliated and community based clinics and community based programs for persons with AIDS. In addition, we contacted leaders of support groups for injection drug users with HIV, persons of color with HIV, and women with HIV and asked them to notify participants of this research opportunity,
The inclusion criteria for physicians was having pro vided primary care for at least 30 patients with AIDS dur ing the physicimfs career, Physicians with HIV experience were identified by key informants at universityaffiliated HIV clinics and through an HIV educational coordinator at major private hospitals providing care to patients with HIV (network sampling). Patients and physicians were told that the focus group would discuss patient physician commu nication for patients with AIDS. but the end-of-life focus was not specified during recruitment. Patients received 810 for participation: physicians were not reimbursed.
Conduct of Focus Groups
Focus groups were formed around key characteristics to enhance group participation. For persons with AIDS, the key characteristics of the groups were as follows: gay or bisexual men (two groups with 9 and 7 participants), women (two groups with 9 and 5 participants), injection drug users (one group with 11 participants), and persons of color (one group with 6 participants). The median age for patients was 38 years with a range of 23 to 58 years: the individual groups did not differ substantially in their median ages, Overall. 16 of the 47 participants were women (including 14 in the women's groups and 2 in the injection drug users' group). Individuals classifying them selves as African American or Latino comprised 17 of 47 patients (including 6 African Americans in the persons of color group, 4 African Americans in the women's groups, 3 Latinas in the women's groups. 3 African Americans in the injection drug users" group, and 1 Latino in the inJec tion drug users" group).
The key characteristic around which the physician groups were formed was university employees or private practitioners. There were 2 groups formed from university affiliated clinics (7 and 5 participants] and one group from community hospitals (7 participants). Overall, women comprised 6 of 19 physicians, and none of the physicians was African Americml or Latino.
Analysis of Transcripts
After initial review of focus group transcripts, investi gators developed a coding scheme for barriers and facilitators to discussing end o51ife care. The transcripts were then reviewed independently by both investigators to clas sify passages (portions of text from a single speaker) into one of 29 barriers and facilitators. To address the trust worthiness of the data, we compared coding across investi gators: we assigned the same code to 63% of the passages, We then reviewed discrepancies and came to consensus for each passage. All barriers or facilitators identified from the transcript review were identified in at least two different focus groups, suggesting that additional groups would not have identified more barriers or facilitators, x 7 Tables 1 and 2 list the 29 barriers and facilitators to patient-physiciml communication about end-of-life care for patients with AIDS. Barriers and facilitators are di vided into those identified in patient and physician focus groups, patient groups only, or physiciml groups only. We present representative quotations to provide context for those barriers and facilitators that we felt were unex pected or particularly important, One of the barriers frequently mentioned by patients and physicians is discomfort discussing death. One pa tient said, "I really didn't think about it when I did [my living will]. I Just answered the questions they asked me. If I was to sit down and think about it, it probably would have bugged me but I Just answered real quick, If I don't take too much time to think about it, it doesn't bother me."
RESU LTS
A physician identified this barrier saying, "It's fun to see p~ tients, mid bringing up such a serious topic as their mortality, particularly for people with HIV infection for whom it is a very stressful and very real part of their 24 hour existence I think it's difficult. It's usually the big elephant in the corner of the room that you don't talk about."
Physicians also worried about undermining a pa tient's hope. One physician said. "I think it's real important not to take their hope away, and I find a barrier to having this conversation is that I might be undermining hope." Another physiciml comments that. "No matter how many times I've done this before, I tell them, 'Look I'm not saying you're gonna die,' and they say, '~vVell, then why are we talking about this?" " Some patients talked extensively about experiencing discrimination in receiving health care. One patient said, "If you're a white heterosexual male that's never been on drugs, you're gonna get a different type of care than if my doctor to know my history around addiction, but it wasn't until I got to know him that I was able to disclose." Several patients and physicimls felt that discussing end-of-life care could cause harm or even death, One patient said, "[My doctor] told me, you gotta do the living will, And I keep saying, okay. I will. I will. I will, But I never told him that I feel that if I sign that thing. I'm gonna die. To me, that's a death warrant. You sign it, you die. That's the way I was raised," Similarly. a physiciml said. "I don't think we really know with a terminal disease like this how negative [end of life discussions] might be and what that does to one's lifestyle and complimlce with medications , . ," Another barrier identified by patients is the idea that patients shouldn't have an end of life discussion until they know what they want at the end of life: "Tm kind of holding out until the miracle happens,,. I wouldn't wink to be on life support, but... I don't want to carve that in stone Just yet. so I don't talk to the doctor about it,"
Some patients feel the need to protect physicians from discussion that they perceive as uncomfortable or even illegal. One patient said. "Tm a little reticent to bring up all these end-of-the-line kind of things, you know. because I'll bum them [clinic staff] out over it." Another pa tient said. "I found myself not telling my doctor what was going on because I didn't wmlt her.., to be upset. I feel like I have the perfect doctor, which makes me want to protect her." Physicians also identified this barrier: "I had a patient who thought it would be illegal for him to talk to me about end-of-life issues, He thought if he asked me for help at the end of life, he was going to Jeopardize my med ical license, , . he kept mlswering, no. he wasn't ready to give up because he thought it would be wrong for him to talk to me about my helping him to be more comfortable."
Several patients perceive the living will as obviating the need to discuss end-of-life care with physicians, It was common for patients to express the sentiment of one patient: "I Just filled [the living will] out mid gave it to the doctor and that's all they required. They put it in your file and that's the way it's done." Another patient expressed this same view: "When you do the papers, it pretty well lays it out there, It makes it clear. You've written it down. End of discussion. You don't.., worry about it any more." Finally. some patients feel they should wait for their doctors to raise these issues, while some doctors feel they should walt until the patient raises the issue. One patient said. "I would be a hell of a lot more conffortable if my doctor would come to me and say 'We need to talk about this.'" One physician expressed the opposite view: "You have to wait for [patients] to bring it up because they live it all the time . . , and I think part of the reason you don't bring it up is because you want them to bring it up. You have to give them a certain amount of denial. , , They're the ones who have to cross that border." 
DISCUSSION
Interventions designed to improve the quality of endof life care, such as advance directives, facilitating patient physiciml communication, or providing state-of-the-art prognostic information, have been disappointing, ~,l~-;n One potential explanation for these negative trials is that not all barriers to discussing end-of-life care have been overcome by the designed interventions, iS Some barriers to patient physician communication found in this study have been identified previously, For example, previous studies have demonstrated that physicians are reluctant to discuss death with their patients.:l,:: Several barriers to communication about end-of-life care. however, have not, to our knowledge, been previously identified. These barriers include patients" avoidance of end-of-life discussions in order to protect health care providers, the living will as a barrier because it obviates discussion between physician and patient, mid physician fears that discussion about end-of-life care will lead patients to perceive the physicians as not being aggressive enough. The iden tification of the living will as a barrier to end-offlife discussion is particularly important because it is seen by many as a facilitator to these discussions.
Of the many other barriers we identified, one deserves further comment. Some patients and physicians were concerned that discussing end of life care may be hamfful to the patient and may even hasten death, This concert1 was raised in a study showing that some NavaJo subjects believed discussion of advance directives could precipitate illness or death, :s There have also been reports of cases in which end-of-life discussion seemed to cause psychological pain. ~4 Although several studies have shown that the majority of patients with AIDS want to discuss end-of-life care with their physicians. 4,1;,13 health care providers should be aware that some patients may feel these discussions can cause harm, Providers should give their patients the opportunity to express this concern,
The focus group participants in this study identified They found that medical residents spent most of the time talking and missed many opportunities to allow patients to discuss their personal values and goals of therapy, These studies suggest that the quality of communication about end 05life care is poor and unlikely to improve with our current medical education. Some barriers found in this study may be addressed by physician and patient education. For example, pa tients should be made aware that the living will does not obviate discussion and that discussion about end-offlife care can occur before making "a final decision" about the end-of-life care. In addition, physicians should be aware that patients may be reluctant to discuss end-of-life care out of concern for protecting the physician or because of past experiences with discrimination from the health care system. Similarly. some facilitators may be useful to physicians attempting to have these discussions with pa tients. For example, focusing on the quality of life remaining may help patients think about difficult issues involved in limiting aggressive medical care. Scheduling Joint ap pointments with patients and their family or friends may also facilitate these discussions, Other barriers to end-off life communication, such as discomfort discussing death and the potential for end-of-life discussion to cause harm. 
